[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hepatitis B Vaccine (Recombinant) Market Status, Trends and COVID-19 Impact Report 2022

February 2023 | 117 pages | ID: G2CFA560A254EN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Hepatitis B Vaccine (Recombinant) market experienced a huge change under the influence of COVID-19 and Russia-Ukraine War, the global market size of Hepatitis B Vaccine (Recombinant) reached XXX million $ in 2022 from XXX in 2017 with a CAGR of 15 from 2017-2022. Facing the complicated international situation, the future of the Hepatitis B Vaccine (Recombinant) market is full of uncertain. BisReport predicts that the global Hepatitis B Vaccine (Recombinant) market size will reach XXX million $in 2028 with a CAGR of xx% from 2022-2028.

Since the outbreak of COVID-19, the world economy continues to suffer from a series of destabilizing shocks, many companies experienced bankruptcy and a sharp decline in turnover. After more than two years of pandemic, global economy began to recover, entering 2022, the Russian Federation’s invasion of Ukraine and its global effects on commodity markets, supply chains, inflation, and financial conditions have steepened the slowdown in global growth. In particular, the war in Ukraine is leading to soaring prices and volatility in energy markets, with improvements in activity in energy exporters more than offset by headwinds to activity in most other economies. The invasion of Ukraine has also led to a significant increase in agricultural commodity prices, which is exacerbating food insecurity and extreme poverty in many emerging market and developing economies.

Numerous risks could further derail what is now a precarious recovery. Among them is, in particular, the possibility of stubbornly high global inflation accompanied by tepid growth, reminiscent of the stagflation of the 1970s. This could eventually result in a sharp tightening of monetary policy in advanced economies to rein in inflation, lead to surging borrowing costs, and possibly culminate in financial stress in some emerging market and developing economies. A forceful and wide-ranging policy response is required by policy makers in these economies and the global community to boost growth, bolster macroeconomic frameworks, reduce financial vulnerabilities, provide support to vulnerable population groups, and attenuate the long-term impacts of the global shocks of recent years.

In this complex international situation, BisReport published Global Hepatitis B Vaccine (Recombinant) Market Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the global Hepatitis B Vaccine (Recombinant) market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type segment, application segment, channel segment etc. historic data period is from 2017-2022, the forecast data from 2023-2028.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
GSK
Merck
Sanofi Pasteur
Dynavax Technologies
LG Life Sciences
KM Biologics
Shenzhen Kangtai Biological Products
Serum Institute

Section 4: 900 USD——Region Segment
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Russia, Italy)
Middle East and Africa (Middle East, South Africa, Egypt)

Section (5 6 7): 700 USD——
Product Type Segment
10mcg/0.5ml
10mcg/ml

Application Segment
Newborn
Adult

Channel Segment (Direct Sales, Distribution Channel)

Section 8: 500 USD——Market Forecast (2023-2028)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source
SECTION 1 HEPATITIS B VACCINE (RECOMBINANT) MARKET OVERVIEW

1.1 Hepatitis B Vaccine (Recombinant) Market Scope
1.2 COVID-19 Impact on Hepatitis B Vaccine (Recombinant) Market
1.3 Global Hepatitis B Vaccine (Recombinant) Market Status and Forecast Overview
  1.3.1 Global Hepatitis B Vaccine (Recombinant) Market Status 2017-2022
  1.3.2 Global Hepatitis B Vaccine (Recombinant) Market Forecast 2023-2028
1.4 Global Hepatitis B Vaccine (Recombinant) Market Overview by Region
1.5 Global Hepatitis B Vaccine (Recombinant) Market Overview by Type
1.6 Global Hepatitis B Vaccine (Recombinant) Market Overview by Application

SECTION 2 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Hepatitis B Vaccine (Recombinant) Sales Volume
2.2 Global Manufacturer Hepatitis B Vaccine (Recombinant) Business Revenue
2.3 Global Manufacturer Hepatitis B Vaccine (Recombinant) Price

SECTION 3 MANUFACTURER HEPATITIS B VACCINE (RECOMBINANT) BUSINESS INTRODUCTION

3.1 GSK Hepatitis B Vaccine (Recombinant) Business Introduction
  3.1.1 GSK Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Revenue and Gross margin 2017-2022
  3.1.2 GSK Hepatitis B Vaccine (Recombinant) Business Distribution by Region
  3.1.3 GSK Interview Record
  3.1.4 GSK Hepatitis B Vaccine (Recombinant) Business Profile
  3.1.5 GSK Hepatitis B Vaccine (Recombinant) Product Specification
3.2 Merck Hepatitis B Vaccine (Recombinant) Business Introduction
  3.2.1 Merck Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Revenue and Gross margin 2017-2022
  3.2.2 Merck Hepatitis B Vaccine (Recombinant) Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 Merck Hepatitis B Vaccine (Recombinant) Business Overview
  3.2.5 Merck Hepatitis B Vaccine (Recombinant) Product Specification
3.3 Manufacturer three Hepatitis B Vaccine (Recombinant) Business Introduction
  3.3.1 Manufacturer three Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Revenue and Gross margin 2017-2022
  3.3.2 Manufacturer three Hepatitis B Vaccine (Recombinant) Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Hepatitis B Vaccine (Recombinant) Business Overview
  3.3.5 Manufacturer three Hepatitis B Vaccine (Recombinant) Product Specification
3.4 Manufacturer four Hepatitis B Vaccine (Recombinant) Business Introduction
  3.4.1 Manufacturer four Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Revenue and Gross margin 2017-2022
  3.4.2 Manufacturer four Hepatitis B Vaccine (Recombinant) Business Distribution by Region
  3.4.3 Interview Record
  3.4.4 Manufacturer four Hepatitis B Vaccine (Recombinant) Business Overview
  3.4.5 Manufacturer four Hepatitis B Vaccine (Recombinant) Product Specification
3.5
3.6

SECTION 4 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) MARKET SEGMENT (BY REGION)

4.1 North America Country
  4.1.1 United States Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.1.2 Canada Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.1.3 Mexico Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
4.2 South America Country
  4.2.1 Brazil Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.2.2 Argentina Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
4.3 Asia Pacific
  4.3.1 China Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.3.2 Japan Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.3.3 India Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.3.4 Korea Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.3.5 Southeast Asia Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
4.4 Europe Country
  4.4.1 Germany Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.4.2 UK Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.4.3 France Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.4.4 Spain Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.4.5 Russia Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.4.6 Italy Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
4.5 Middle East and Africa
  4.5.1 Middle East Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.5.2 South Africa Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
  4.5.3 Egypt Hepatitis B Vaccine (Recombinant) Market Size and Price Analysis 2017-2022
4.6 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Region) Analysis 2017-2022
4.7 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Country) Analysis 2017-2022
4.8 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Region) Analysis

SECTION 5 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) MARKET SEGMENT (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 10mcg/0.5ml Product Introduction
  5.1.2 10mcg/ml Product Introduction
5.2 Global Hepatitis B Vaccine (Recombinant) Sales Volume (by Type) 2017-2022
5.3 Global Hepatitis B Vaccine (Recombinant) Market Size (by Type) 2017-2022
5.4 Different Hepatitis B Vaccine (Recombinant) Product Type Price 2017-2022
5.5 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Type) Analysis

SECTION 6 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) MARKET SEGMENT (BY APPLICATION)

6.1 Global Hepatitis B Vaccine (Recombinant) Sales Volume (by Application) 2017-2022
6.2 Global Hepatitis B Vaccine (Recombinant) Market Size (by Application) 2017-2022
6.3 Hepatitis B Vaccine (Recombinant) Price in Different Application Field 2017-2022
6.4 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Application) Analysis

SECTION 7 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) MARKET SEGMENT (BY CHANNEL)

7.1 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Channel) Sales Volume and Share 2017-2022
7.2 Global Hepatitis B Vaccine (Recombinant) Market Segment (By Channel) Analysis

SECTION 8 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) MARKET FORECAST 2023-2028

8.1 Hepatitis B Vaccine (Recombinant) Segment Market Forecast 2023-2028 (By Region)
8.2 Hepatitis B Vaccine (Recombinant) Segment Market Forecast 2023-2028 (By Type)
8.3 Hepatitis B Vaccine (Recombinant) Segment Market Forecast 2023-2028 (By Application)
8.4 Hepatitis B Vaccine (Recombinant) Segment Market Forecast 2023-2028 (By Channel)
8.5 Global Hepatitis B Vaccine (Recombinant) Price (USD/Unit) Forecast

SECTION 9 HEPATITIS B VACCINE (RECOMBINANT) APPLICATION AND CUSTOMER ANALYSIS

9.1 Newborn Customers
9.2 Adult Customers

SECTION 10 HEPATITIS B VACCINE (RECOMBINANT) MANUFACTURING COST OF ANALYSIS

10.1 Raw Material Cost Analysis
10.2 Labor Cost Analysis
10.3 Cost Overview

SECTION 11 CONCLUSION

12 RESEARCH METHOD AND DATA SOURCE

CHART AND FIGURE

Figure Hepatitis B Vaccine (Recombinant) Product Picture
Chart Global Hepatitis B Vaccine (Recombinant) Market Size (with or without the impact of COVID-19)
Chart Global Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Growth Rate 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Size (Million $) and Growth Rate 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Growth Rate 2023-2028
Chart Global Hepatitis B Vaccine (Recombinant) Market Size (Million $) and Growth Rate 2023-2028
Table Global Hepatitis B Vaccine (Recombinant) Market Overview by Region
Table Global Hepatitis B Vaccine (Recombinant) Market Overview by Type
Table Global Hepatitis B Vaccine (Recombinant) Market Overview by Application
Chart 2017-2022 Global Manufacturer Hepatitis B Vaccine (Recombinant) Sales Volume (Units)
Chart 2017-2022 Global Manufacturer Hepatitis B Vaccine (Recombinant) Sales Volume Share
Chart 2017-2022 Global Manufacturer Hepatitis B Vaccine (Recombinant) Business Revenue (Million USD)
Chart 2017-2022 Global Manufacturer Hepatitis B Vaccine (Recombinant) Business Revenue Share
Chart 2017-2022 Global Manufacturer Hepatitis B Vaccine (Recombinant) Business Price (USD/Unit)
Chart GSK Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Revenue and Gross margin 2017-2022
Chart GSK Hepatitis B Vaccine (Recombinant) Business Distribution
Chart GSK Interview Record (Partly)
Chart GSK Hepatitis B Vaccine (Recombinant) Business Profile
Table GSK Hepatitis B Vaccine (Recombinant) Product Specification
Chart United States Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart United States Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Canada Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Canada Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Mexico Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Mexico Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Brazil Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Brazil Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Argentina Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Argentina Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart China Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart China Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Japan Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Japan Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart India Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart India Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Korea Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Korea Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Southeast Asia Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Southeast Asia Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Germany Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Germany Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart UK Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart UK Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart France Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart France Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Spain Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Spain Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Russia Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Russia Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Italy Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Italy Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Middle East Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Middle East Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart South Africa Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart South Africa Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Egypt Hepatitis B Vaccine (Recombinant) Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Egypt Hepatitis B Vaccine (Recombinant) Sales Price (USD/Unit) 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Sales Volume (Units) by Region 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Sales Volume (Units) Share by Region 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Market size (Million $) by Region 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Market size (Million $) Share by Region 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Sales Volume (Units) by Country 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Sales Volume (Units) Share by Country 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Market size (Million $) by Country 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment Market size (Million $) Share by Country 2017-2022
Chart 10mcg/0.5ml Product Figure
Chart 10mcg/0.5ml Product Description
Chart 10mcg/ml Product Figure
Chart 10mcg/ml Product Description
Chart Hepatitis B Vaccine (Recombinant) Sales Volume by Type (Units) 2017-2022
Chart Hepatitis B Vaccine (Recombinant) Sales Volume (Units) Share by Type
Chart Hepatitis B Vaccine (Recombinant) Market Size by Type (Million $) 2017-2022
Chart Hepatitis B Vaccine (Recombinant) Market Size (Million $) Share by Type
Chart Different Hepatitis B Vaccine (Recombinant) Product Type Price (USD/Unit) 2017-2022
Chart Hepatitis B Vaccine (Recombinant) Sales Volume by Application (Units) 2017-2022
Chart Hepatitis B Vaccine (Recombinant) Sales Volume (Units) Share by Application
Chart Hepatitis B Vaccine (Recombinant) Market Size by Application (Million $) 2017-2022
Chart Hepatitis B Vaccine (Recombinant) Market Size (Million $) Share by Application
Chart Hepatitis B Vaccine (Recombinant) Price in Different Application Field 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment (By Channel) Sales Volume (Units) 2017-2022
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment (By Channel) Share 2017-2022
Chart Hepatitis B Vaccine (Recombinant) Segment Market Sales Volume (Units) Forecast (by Region) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Segment Market Sales Volume Forecast (By Region) Share 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Segment Market Size (Million USD) Forecast (By Region) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Segment Market Size Forecast (By Region) Share 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Type) Volume (Units) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Type) Volume (Units) Share 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Type) Market Size (Million $) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Type) Market Size (Million $) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Application) Market Size (Volume) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Application) Market Size (Volume) Share 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Application) Market Size (Value) 2023-2028
Chart Hepatitis B Vaccine (Recombinant) Market Segment (By Application) Market Size (Value) Share 2023-2028
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment (By Channel) Sales Volume (Units) 2023-2028
Chart Global Hepatitis B Vaccine (Recombinant) Market Segment (By Channel) Share 2023-2028
Chart Global Hepatitis B Vaccine (Recombinant) Price Forecast 2023-2028
Chart Newborn Customers
Chart Adult Customers


More Publications